|
⚲
|
| Keyboard |
| Mark Frohlich | |
|---|---|
| Firm | |
| Address | 5000 Gulf Fwy Building 4 Room 118 Houston, TX 77023 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Indapta Therapeutics Inc | 021-560578 | Executive Officer | 50.8 M of 51.6 M |
||
| Indapta Therapeutics Inc | 021-433098 | Executive Officer | 33.6 M of 67.1 M |
||
| Bioeclipse Therapeutics Inc | 021-342724 | Director | 10.1 M of 11.8 M |
||
| Juno Therapeutics Inc | 021-243722 | Executive Officer | 898.5 M | ||
| Juno Therapeutics Inc | 021-222931 | Executive Officer | 85.5 M of 133.7 M |
||